Key Takeaways
- • HIVE Digital (NASDAQ: HIVE) announced a private offering of US$75 million in 0% exchangeable senior notes due 2031, with an additional US$15 million option for initial purchasers, targeting qualified institutional buyers under Rule 144A.
- • Net proceeds will fund subsidiary capital investments in graphics processing units and data center development to support AI compute and digital infrastructure expansion, with capped call transactions designed to limit shareholder dilution upon note conversion.
- • HIVE received conditional approval for Toronto Stock Exchange (TSX) listing, with trading expected to migrate from TSX Venture Exchange on or around April 30, 2026, subject to meeting all TSX requirements by June 30, 2026.
- • Notes are senior unsecured obligations fully guaranteed by HIVE, with settlement flexibility allowing the issuer to pay or deliver cash, common shares, or a combination thereof at its election.
- • Stock declined 14.78% following the announcement, reflecting market concern over potential share dilution and unsecured debt obligations, erasing approximately $92 million in market capitalization.
Summary
HIVE Digital Technologies Ltd., a global provider of sustainable digital infrastructure and AI compute services, announced on April 15, 2026, a private offering of US$75 million in 0% exchangeable senior notes due 2031. The offering, which is being conducted through HIVE Bermuda 2026 Ltd., a wholly-owned subsidiary, includes an option for initial purchasers to acquire up to an additional US$15 million in notes within 13 days of issuance. The notes are being offered to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933 and are general unsecured obligations fully guaranteed on a senior unsecured basis by HIVE.
The zero-coupon structure eliminates regular interest payments and accruing principal, providing HIVE with favorable debt economics. The notes will be exchangeable under certain conditions, with the issuer retaining flexibility to settle exchanges through cash, common shares of HIVE, or a combination thereof, to be determined at the time of pricing. The initial exchange rate and other material terms are to be established at pricing.
Proceeds from the offering are earmarked for subsidiary subscriptions to fund general corporate purposes and capital investments, with primary focus on acquiring graphics processing units and developing data center infrastructure to support HIVE's AI and high-performance computing expansion strategy. Additionally, HIVE intends to utilize cash on hand and potentially note proceeds to fund capped call transactions designed to economically limit potential shareholder dilution triggered by note exchanges within a specified pricing cap.
Concurrent with the financing announcement, HIVE received conditional approval to list its common shares on the Toronto Stock Exchange, representing a strategic up-listing from the TSX Venture Exchange. Trading on the TSX is expected to commence on or around April 30, 2026, subject to the company meeting all applicable TSX requirements by June 30, 2026. This dual capital market strategy positions HIVE for enhanced liquidity and broader institutional investor access while executing its infrastructure and AI compute investment roadmap.
The market reacted negatively to the announcement, with HIVE shares declining 14.78% to $2.10 per share, erasing approximately $92 million in market capitalization. This decline reflects investor concerns regarding potential share dilution upon note conversion and the unsecured nature of the debt obligations, despite the capped call hedging mechanisms designed to limit dilution exposure.
The zero-coupon structure eliminates regular interest payments and accruing principal, providing HIVE with favorable debt economics. The notes will be exchangeable under certain conditions, with the issuer retaining flexibility to settle exchanges through cash, common shares of HIVE, or a combination thereof, to be determined at the time of pricing. The initial exchange rate and other material terms are to be established at pricing.
Proceeds from the offering are earmarked for subsidiary subscriptions to fund general corporate purposes and capital investments, with primary focus on acquiring graphics processing units and developing data center infrastructure to support HIVE's AI and high-performance computing expansion strategy. Additionally, HIVE intends to utilize cash on hand and potentially note proceeds to fund capped call transactions designed to economically limit potential shareholder dilution triggered by note exchanges within a specified pricing cap.
Concurrent with the financing announcement, HIVE received conditional approval to list its common shares on the Toronto Stock Exchange, representing a strategic up-listing from the TSX Venture Exchange. Trading on the TSX is expected to commence on or around April 30, 2026, subject to the company meeting all applicable TSX requirements by June 30, 2026. This dual capital market strategy positions HIVE for enhanced liquidity and broader institutional investor access while executing its infrastructure and AI compute investment roadmap.
The market reacted negatively to the announcement, with HIVE shares declining 14.78% to $2.10 per share, erasing approximately $92 million in market capitalization. This decline reflects investor concerns regarding potential share dilution upon note conversion and the unsecured nature of the debt obligations, despite the capped call hedging mechanisms designed to limit dilution exposure.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.